XML 32 R20.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information
6 Months Ended
Sep. 28, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
Effective beginning with the first fiscal quarter of fiscal 2026, we realigned our reporting segments to reflect organizational changes made and to reflect the way we manage our operations and allocate resources. We believe this realignment better reflects the value our company provides to our customers and our evolution from a bulk commodity distributor into a specialty ingredients company. In fiscal 2026, we organize and manage our business by the following three segments, each of which meets the definition of reportable segments under ASC 280-10, Segment Reporting: Water Treatment, Food & Health Sciences, and Industrial Solutions. These segments are defined primarily by product and type of customer.
Our chief operating decision-maker (CODM), who is our President and Chief Executive Officer, regularly reviews the consolidated financial statements in their entirety and financial information at the reportable segment level. The CODM uses operating income and considers budget-to-actual variances on a quarterly basis when making decisions about the allocation of operating and capital resources to each segment. The CODM also uses segment operating income for evaluating pricing strategy, to assess the performance of each segment by comparing the results of each segment with one another, and in determining the compensation of certain employees. The CODM has ultimate responsibility for enterprise decisions and making resource allocation decisions for the Company and the segments.
Our Water Treatment segment specializes in providing chemicals, products, equipment, services and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water and agricultural water. This segment has the resources and flexibility to treat systems ranging in size from a single small well to a multi-million-gallon-per-day facility.
Our Food & Health Sciences segment specializes in processing and formulation solutions as well as ingredient distribution to manufacturers in the nutrition, food, pharmaceutical, and agricultural markets. This segment offers a diverse product portfolio including base chemistry, acid based reactions, minerals, vitamins and amino acids, excipients, botanicals and herbs, sweeteners and enzymes, fertilizers, and food-grade and pharmaceutical salts and ingredients.
Our Industrial Solutions segment specializes in providing industrial chemicals, products and services to industries such as industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing. This segment’s principal products are acids and alkalis.
The accounting policies of the segments are the same as those described in the summary of significant accounting policies. Product costs and expenses for each segment are based on actual costs incurred along with cost allocations of shared and centralized functions.
There are no intersegment sales and no operating segments have been aggregated.
In fiscal 2026 and 2025, none of our customers accounted for 10% or more of our total sales.
Summarized financial information for our reportable segments is presented and reconciled to consolidated financial information in the following tables:
(In thousands)Water
Treatment
Food & Health SciencesIndustrial SolutionsTotal
Three months ended September 28, 2025:
Sales$150,908 $72,914 $56,612 $280,434 
Cost of sales - materials88,814 53,153 45,131 187,098 
Cost of sales - operational overhead18,833 4,280 2,580 25,693 
Gross profit43,261 15,481 8,901 67,643 
Selling, general, and administrative expenses22,071 8,084 3,548 33,703 
Operating income21,190 7,397 5,353 33,940 
Interest expense, net(3,832)
Other income721 
Income tax expense(8,231)
Net income22,598 
Identifiable assets*569,338 247,644 135,082 952,064 
Capital expenditures7,033 1,774 1,991 10,798 
Depreciation and amortization7,854 3,214 2,194 13,262 
Three months ended September 29, 2024:
Sales$124,528 $71,402 $51,099 $247,029 
Cost of sales - materials71,264 51,054 40,305 162,623 
Cost of sales - operational overhead17,336 4,283 2,565 24,184 
Gross profit35,928 16,065 8,229 60,222 
Selling, general, and administrative expenses15,825 7,456 3,196 26,477 
Operating income20,103 8,609 5,033 33,745 
Interest expense, net(1,427)
Other income673 
Income tax expense(8,873)
Net income24,118 
Identifiable assets*292,017 239,639 130,091 661,747 
Capital expenditures5,428 2,421 2,788 10,637 
Depreciation and amortization4,693 3,122 2,112 9,927 
(In thousands)Water
Treatment
Food & Health SciencesIndustrial SolutionsTotal
Six months ended September 28, 2025:
Sales$300,474 $162,091 $111,141 $573,706 
Cost of sales - materials177,973 118,967 87,979 384,919 
Cost of sales - operational overhead35,493 8,295 4,994 48,782 
Gross profit87,008 34,829 18,168 140,005 
Selling, general, and administrative expenses41,156 16,465 7,111 64,732 
Operating income45,852 18,364 11,057 75,273 
Interest expense, net(7,101)
Other income1,663 
Income tax expense(18,062)
Identifiable assets*
Capital expenditures14,593 4,787 4,962 24,342 
Depreciation and amortization14,758 6,414 4,381 25,553 
Six months ended September 29, 2024:
Sales$241,704 $156,495 $104,709 $502,908 
Cost of sales - materials137,261 112,601 82,246 332,108 
Cost of sales - operational overhead33,307 7,926 4,690 45,923 
Gross profit71,136 35,968 17,773 124,877 
Selling, general, and administrative expenses29,904 14,821 6,616 51,341 
Operating income41,232 21,147 11,157 73,536 
Interest expense, net(2,690)
Other income832 
Income tax expense(18,681)
Identifiable assets*
Capital expenditures11,549 4,582 5,155 21,286 
Depreciation and amortization8,864 6,211 4,181 19,256 
*Unallocated assets not included, consisting primarily of cash and cash equivalents, prepaid expenses, and non-qualified deferred compensation plan assets of $32.1 million at September 28, 2025 and $28.0 million at September 29, 2024.